Ultragenyx Pharmaceutical | RARE - Activos Circulantes





Activos Circulantes Cambio Fecha
Acadia Pharmaceuticals USD 1.27B 43.88M 2026-09
Agios Pharmaceuticals USD 752.1M 34.43M 2026-09
Alnylam Pharmaceuticals USD 5.11B 492.49M 2026-09
BioCryst Pharmaceuticals USD 531.15M 46.47M 2026-09
BioMarin Pharmaceutical USD 3.92B 50.99M 2026-09
Immunic USD 188.76M 165.89M 2026-03
Insmed USD 1.71B 72.59M 2026-09
Ionis Pharmaceuticals USD 2.49B 446.73M 2026-06
Karyopharm Therapeutics USD 126.33M 23.19M 2026-03
Kyowa Hakko Kirin JPY 482.59B 35.17B 2026-09
MacroGenics USD 321.69M 139.16M 2026-06
Moderna USD 7.34B 1.53B 2026-09
Neurocrine Biosciences USD 2.01B 370.7M 2026-09
PTC Therapeutics USD 2.54B 79.58M 2026-09
Puma Biotechnology USD 143.58M 7M 2025-09
Regeneron Pharmaceuticals USD 20.8B 2.35B 2026-09
Sarepta Therapeutics USD 2.27B 49.06M 2026-09
Ultragenyx Pharmaceutical USD 544M 62M 2026-09
Vertex Pharmaceuticals USD 11.69B 857.4M 2026-09